ATE398444T1 - Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt - Google Patents

Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt

Info

Publication number
ATE398444T1
ATE398444T1 AT05803087T AT05803087T ATE398444T1 AT E398444 T1 ATE398444 T1 AT E398444T1 AT 05803087 T AT05803087 T AT 05803087T AT 05803087 T AT05803087 T AT 05803087T AT E398444 T1 ATE398444 T1 AT E398444T1
Authority
AT
Austria
Prior art keywords
solid dosage
powder
freeze drying
water
production
Prior art date
Application number
AT05803087T
Other languages
English (en)
Inventor
Kurt Heinz Bauer
Original Assignee
Pantec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE398444(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pantec Ag filed Critical Pantec Ag
Application granted granted Critical
Publication of ATE398444T1 publication Critical patent/ATE398444T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Drying Of Solid Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05803087T 2004-10-28 2005-10-27 Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt ATE398444T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04105381 2004-10-28

Publications (1)

Publication Number Publication Date
ATE398444T1 true ATE398444T1 (de) 2008-07-15

Family

ID=34929781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05803087T ATE398444T1 (de) 2004-10-28 2005-10-27 Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt

Country Status (18)

Country Link
US (1) US8802145B2 (de)
EP (1) EP1804764B1 (de)
JP (1) JP4980228B2 (de)
KR (1) KR101379297B1 (de)
CN (2) CN102631289B (de)
AT (1) ATE398444T1 (de)
BR (1) BRPI0517256B8 (de)
CA (1) CA2585426C (de)
CY (1) CY1108343T1 (de)
DE (1) DE602005007624D1 (de)
DK (1) DK1804764T3 (de)
ES (1) ES2308566T3 (de)
HK (1) HK1171364A1 (de)
IL (1) IL182745A (de)
PL (1) PL1804764T3 (de)
PT (1) PT1804764E (de)
SI (1) SI1804764T1 (de)
WO (1) WO2006045830A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
CN106666722B (zh) * 2017-03-13 2019-03-22 广州正广生物科技有限公司 一种螺旋藻片及其制备方法
BR112021006668A2 (pt) 2018-10-15 2021-07-06 Aprecia Pharmaceuticals LLC método e sistema para formar uma forma de dosagem dentro de uma embalagem
GB2585413B (en) 2019-02-22 2023-04-26 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
GB2585411B (en) 2019-02-22 2023-10-04 Catalent Uk Swindon Zydis Ltd Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
TW202045153A (zh) * 2019-02-22 2020-12-16 英商康泰倫特英國斯文敦載迪斯有限公司 含伊布洛芬之醫藥組合物之塗層之黏聚最小化、通氣及保存
AU2020224375A1 (en) * 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
ATE24964T1 (de) * 1981-12-11 1987-01-15 Wyeth John & Brother Ltd Verfahren zur herstellung von festen formgegenstaenden.
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
EP1598061B1 (de) * 1996-06-14 2010-08-18 Kyowa Hakko Kirin Co., Ltd. Eine im Mund schnell zerfallende Tablette
US5976577A (en) 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
WO2001012161A1 (en) * 1999-08-17 2001-02-22 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
EP1166655A1 (de) * 2000-06-19 2002-01-02 Société des Produits Nestlé S.A. Brett-stabiles oder gekühltes Schaumprodukt und Verfahren zur seiner Herstellung
CN1290525A (zh) * 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US6509040B1 (en) * 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
CN1197556C (zh) * 2003-02-12 2005-04-20 刘智 一种防治放疗、化疗呕吐的口腔快速崩解片剂及制备方法
US20050036977A1 (en) 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof

Also Published As

Publication number Publication date
KR101379297B1 (ko) 2014-04-10
IL182745A (en) 2010-06-30
CY1108343T1 (el) 2014-02-12
ES2308566T3 (es) 2008-12-01
IL182745A0 (en) 2007-07-24
BRPI0517256B8 (pt) 2021-05-25
US20090062241A1 (en) 2009-03-05
CA2585426C (en) 2013-05-14
CN102631289A (zh) 2012-08-15
DK1804764T3 (da) 2008-09-29
PT1804764E (pt) 2008-09-11
EP1804764B1 (de) 2008-06-18
CN102631289B (zh) 2016-05-04
WO2006045830A1 (en) 2006-05-04
PL1804764T3 (pl) 2008-11-28
DE602005007624D1 (de) 2008-07-31
JP2008517979A (ja) 2008-05-29
SI1804764T1 (sl) 2008-10-31
HK1171364A1 (zh) 2013-03-28
EP1804764A1 (de) 2007-07-11
CA2585426A1 (en) 2006-05-04
BRPI0517256B1 (pt) 2018-11-21
KR20070069179A (ko) 2007-07-02
JP4980228B2 (ja) 2012-07-18
CN101065105A (zh) 2007-10-31
US8802145B2 (en) 2014-08-12
BRPI0517256A (pt) 2008-10-07

Similar Documents

Publication Publication Date Title
ATE398444T1 (de) Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt
WO2014059252A3 (en) Personal care composition in the form of a dissolvable article
MY178686A (en) Stabilizing composition for biological materials
RU2016122882A (ru) Способ получения фармацевтических композиций для лечения опосредованных cftr заболеваний
WO2010126708A3 (en) Articles and methods of manufacture of articles
WO2012149069A3 (en) Stable solid form agave sweeteners and methods for manufacture thereof
WO2007038586A3 (en) Methods to reduce organic impurity levels in polymers and products made therefrom
DK1631373T3 (da) Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse
DK1735005T3 (da) Fremgangsmåde til indkapsling af oralt indtagne materialer til ændring af fordøjelsesstedet, virkningsstedet eller stabiliteten
RU2500650C1 (ru) Комплексная разжижающая добавка для керамических шликеров, применяемых при изготовлении керамических изделий методом литья в гипсовых формах
DE602004010097D1 (de) Piezoelektrische kompositmaterialien und herstellungsverfahren dafür
WO2007054292A3 (en) Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
NZ629598A (en) Stable bioactive substances and methods of making
AR062924A1 (es) Produccion de una composicion pirotecnica de retardo
CN107913500A (zh) 利用植物秸秆配制高尔夫球钉
RU2008149403A (ru) Способ изготовления арболита
RU2489228C1 (ru) Способ получения гранулированной алюминиевой пудры
TH116824B (th) องค์ประกอบทางเภสัชกรรมแบบของแข็งชนิดต่างๆ และกระบวนการการต่างๆ สำหรับการผลิตองค์ประกอบดังกล่าว
JP2004340498A (ja) 風化珊瑚利用のマイナスイオン発生電気冷蔵・冷凍と電気冷蔵・冷凍庫用マイナスイオン発生珊瑚体
TH166935A (th) ปูนซีเมนต์ธรรมชาติจากขยะเหลือบริโภค และวัสดุเหลือใช้
TH13639C3 (th) กรรมวิธีการผลิตแผ่นใยไม้อัดซีเมนต์ที่มีความแข็งแรงสูงจากกากมะพร้าว ต้นข้าวโพด และตะแกรงเหล็ก
TH13639A3 (th) กรรมวิธีการผลิตแผ่นใยไม้อัดซีเมนต์ที่มีความแข็งแรงสูงจากกากมะพร้าว ต้นข้าวโพด และตะแกรงเหล็ก
RS20150331A1 (sr) Segmentni umivaonik od prirodnih materijala-kamena, mermera, granita i dragog kamena i drugih vrsta veštačkih polimernih materijala i postupak za njegovu izradu
TH76530A (th) สารผสมทางเภสัชกรรม
WO2011029979A3 (es) Proceso para la fabricación de materiales aligerados resistentes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1804764

Country of ref document: EP